MedTrace Logo

FLIPS: Ferfer Liposomal Iron Performance Study

NCT03112187 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2019-01-31

No results posted yet for this study

Summary

To evaluate the efficacy of a novel food supplement, Ferfer® to raise the capacity of Haemoglobin and Haematocrit levels

Conditions

Interventions

DRUG

Iron Supplement

Ferfer® is a multi-ingredient supplement containing micro-encapsulated iron pyrophosphate (to form liposomes), vitamin C and vitamin B12 which are valuable for the control of nutritional deficiencies or increased organic needs of iron.

Sponsors & Collaborators

  • PharmEvo Pvt Ltd

    lead INDUSTRY

Principal Investigators

  • Masood Jawaid, MRCS,FCPS · PharmEvo Pvt Ltd

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-11-30
Completion
2019-01-31

Countries

  • Pakistan

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03112187 on ClinicalTrials.gov